UK Life Sciences & Health Market Exploration Mission: Leeds, Huddersfield & Manchester

Task Force Health Care (TFHC) had the opportunity to lead a Dutch delegation of 11 innovative Life Sciences & Health companies on a market exploration mission to Leeds, Huddersfield and Manchester in the United Kingdom. The purpose of this mission was to provide Dutch entrepreneurs with practical insights into the UK healthcare landscape, understand how innovation is adopted within the NHS, and explore opportunities for collaboration and market entry.

Together with Health Innovation Yorkshire & Humber, NBSO Manchester, and a wide range of regional ecosystem partners, we facilitated an intensive three-day programme focused on innovation, commercialisation, research collaboration, and NHS engagement. The mission brought together companies active in digital health & smart care, women’s health, and prevention & population health; Massyst, Medi-Path, Redgrasp Microlearning, Research Manager, Thaumatec, Psylaris, CC Diagnostics, Maternify, EW2Health, mu-drop, and MLM-Tool.

What We Did

During the mission, participants gained firsthand insights into the UK healthcare system and connected with key stakeholders across the NHS and the wider innovation ecosystem. Some of the main activities included:

Learning how the NHS is structured and how innovators can navigate market opportunities, validate solutions, and engage with relevant stakeholders.
Exploring commercialisation pathways, evidence generation requirements, and routes to adoption through sessions with Health Innovation Yorkshire & Humber and the NIHR Leeds Clinical Research Facility.
Visiting leading innovation hubs including Nexus Leeds, Leeds Teaching Hospitals NHS Trust, and the National Health Innovation Campus in Huddersfield.
Meeting with NHS organisations to understand innovation priorities, piloting opportunities, and collaboration mechanisms within healthcare settings.
Exploring funding, investment, and research collaboration opportunities through discussions with UKRI, Medilink North of England, and other ecosystem partners.
Participating in networking events and interactive discussions with NHS leaders, innovation organisations, policymakers, and fellow entrepreneurs.
Learning about NHS priorities in areas such as women’s health, maternity care, health inequalities, prevention, population health, and digital transformation.
Engaging with Health Innovation Manchester and NHS Greater Manchester Integrated Care Board to better understand integrated care, regional innovation strategies, and successful collaborations between innovators and the NHS.

Key Takeaways

Through the various sessions, site visits, and stakeholder discussions, several important insights emerged:

1. A shared vision is driving healthcare transformation across the UK
One of the most notable observations was the strong alignment across NHS organisations, innovation centres, research institutions, and regional authorities. Regardless of the stakeholder, discussions consistently referred back to the ambitions outlined in the NHS 10-Year Health Plan, which focuses on three major shifts:

– From analogue to digital
– From treatment to prevention
– From hospital to community-based care

These priorities are shaping investment decisions, innovation programmes, procurement strategies, and future healthcare delivery models across the UK. For innovators, aligning solutions with these strategic shifts is essential for successful NHS engagement.

2. Focus on the patient pathway, not the product
A recurring message throughout the mission was that NHS organisations are not looking for standalone technologies; they are looking for solutions that improve healthcare pathways and patient outcomes.

Rather than leading with product features, successful innovators demonstrate how their solution integrates into existing clinical workflows, supports healthcare professionals, addresses unmet needs, and contributes to broader system objectives. Understanding the patient journey and the challenges faced by healthcare providers is therefore critical when developing a UK market strategy.

3. There is no single route to market in the NHS
Participants learned that NHS adoption can follow several different pathways depending on the innovation, target audience, and regional context. Three common approaches emerged:

– Bottom-up clinical engagement: building support through clinicians and local champions who can advocate for adoption within their organisation.
– Top-down regional adoption: aligning with strategic priorities of Integrated Care Boards (ICBs), Integrated Care Systems (ICSs), or regional innovation programmes.
– Strategic partnerships: collaborating with established partners, distributors, implementation organisations, or ecosystem players that already have NHS relationships and market access.

While each route can be successful independently, stakeholders emphasised that the strongest market entry strategies often combine elements of all three approaches. Companies that align with regional priorities, secure clinical champions, and leverage strategic partnerships are generally best positioned to achieve sustainable adoption and scale.

4. Evidence and partnerships remain critical for success
Successful adoption within the NHS requires more than a strong technology solution. Companies need robust clinical and economic evidence, meaningful stakeholder engagement, and strong partnerships with healthcare organisations, innovation networks, and research institutions to demonstrate value and build trust.

5. Significant opportunities exist in prevention, digital health and women’s health

The mission highlighted growing NHS demand for solutions that support prevention, population health management, maternity care, women’s health, health inequalities, and digital transformation. These areas align strongly with the expertise of many Dutch health innovators and offer promising opportunities for future collaboration.

What’s Next?

Following the mission, TFHC will continue supporting participating companies in their UK market exploration and partnership development activities. Our next steps include:

– Sharing key findings and opportunities with participating companies and ecosystem partners.
– Facilitating follow-up introductions with relevant NHS organisations and innovation stakeholders.
– Supporting companies in identifying suitable pilot opportunities, funding mechanisms, and market entry pathways.
– Exploring future collaborations with regional partners across Yorkshire and Greater Manchester.
– Building on the strong relationships established during this visit to create new opportunities for Dutch-UK healthcare cooperation.

The mission reinforced the strong alignment between Dutch health innovation strengths and the priorities of the UK healthcare system. We are confident that the connections made and insights gained will contribute to future collaborations and successful market development activities.